Abstract
Cerebrotendinous xanthomatosis (CTX), a rare autosomal recessive lipid storage disorder which is caused by mutations in gene CYP27A1 leads to deficiency of enzyme sterol 27-hydroxylase. Clinically, CTX is characterized by tendon xanthomas, premature atherosclerosis, juvenile cataracts and progressive neurological deficits. In this study, we report one 34 year-old Taiwanese man who developed bilateral xanthomas on Achilles tendon and progressive neuropsychiatric disorder. DNA sequencing revealed novel compound heterozygous mutation of CYP27A1 gene, 1072C > T (Gln358X) in exon 6 and c.496–497, 503–514 deletion in exon 1. Early diagnosis of CTX is crucial because treatment with chenodeoxycholic acid in time may prevent or improve neurological dysfunction.
| Original language | English |
|---|---|
| Pages (from-to) | 200-202 |
| Number of pages | 3 |
| Journal | Dermatologica Sinica |
| Volume | 36 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2018 Dec |
All Science Journal Classification (ASJC) codes
- Dermatology
Fingerprint
Dive into the research topics of 'Cerebrotendinous xanthomatosis-a case report with novel compound heterozygous mutation of CYP27A1 gene'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver